Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Journal of Pharmaceutical Sciences|November 5, 2013
Population pharmacokinetics of rilotumumab, a fully human monoclonal antibody against hepatocyte growth factor, in cancer patientsMin Zhu, Sameer Doshi, Per O Gisleskog, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 8, 2012
Denosumab dose selection for patients with bone metastases from solid tumorsSameer Doshi, Liviawati Sutjandra, Jenny Zheng, et al.
Clinical Pharmacology and Therapeutics|May 8, 2023
Pharmacokinetics and Pharmacokinetic/Pharmacodynamic Properties of Rozibafusp Alfa, a Bispecific Inhibitor of BAFF and ICOSL: Analyses of Phase I Clinical TrialsLubna Abuqayyas, Po-Wei Chen, Marcia Teixeira Dos Santos, et al.
Clinical Pharmacokinetics|November 18, 2011
Population pharmacokinetic meta-analysis of denosumab in healthy subjects and postmenopausal women with osteopenia or osteoporosisLiviawati Sutjandra, Rachelle D Rodriguez, Sameer Doshi, et al.
Clinical Pharmacokinetics|March 17, 2012
Population pharmacokinetic analysis of denosumab in patients with bone metastases from solid tumoursLeonid Gibiansky, Liviawati Sutjandra, Sameer Doshi, et al.
NMR in Biomedicine|September 24, 2004
Quantification of water diffusion and relaxation times of human U87 tumors in a mouse modelYanping Sun, Robert V Mulkern, Karl Schmidt, et al.
Pageof 4